References

American Lung Association (ALA) (2013). Extensively Drug-Resistant Tuberculosis (XDR TB) Fact Sheet. Retrieved from http://www.lung.org/lung-disease/tuberculosis/factsheets/extensively-drug-resistant.html American Lung Association (ALA) (2013). Multiple Drug-Resistant Tuberculosis (MDR-TBMDR-TB) Fact Sheet. Retrieved from: http://www.lung.org/lung-disease/tuberculosis/factsheets/multidrug-resistant.html
Belknap R., Weis S., Brookens A., Au-Yeung K.Y., Moon G., et al. (2013). Feasibility of an Ingestible Sensor-Based System for Monitoring Adherence to Tuberculosis Therapy. PLoS ONE 8(1): e53373. doi:10.1371/journal.pone.0053373
Bwanga, F., Hoffner, S., Haile, M., Joloba, M. (2009). Direct Susceptibility Testing for a Multi Drug Resistant Tuberculosis: A Meta-Analysis. (2009). BioMed Central Infectious Diseases (9:67). doi:10.1186/1471-2334-9-67 Centers for Disease Control and Prevention (CDC). 2008. Emergence of Extensively Drug Resistant Tuberculosis. http://www2c.cdc.gov/podcasts/player.asp?f=4733
Centers for Disease Control and Prevention (CDC): Division of Tuberculosis Elimination (2012). Tuberculosis: Drug Resistant TB. Retrieved from: http://www.cdc.gov/tb/topic/drtb/default.html Center for Disease Control (CDC) (1993). Initial Therapy for Tuberculosis in the Era of Multidrug Resistance -- Recommendations of the Advisory Council for the Elimination of Tuberculosis. Retrieved from: http://www.cdc.gov/mmwr/preview/mmwrhtml/00020964.htm
HIV Web Study. (2010). [Kaplain-Meier survival plot among MDR-TB and XDR-TB patients co-infected with HIV, 2005 to 2007]. HIV Coinfection in Multidrug- and Extensively Drug-resistant Tuberculosis Results in High Early Mortality. Retrieved from http://depts.washington.edu/ghivaids/reslimited/case6/discussion.html Kempker, R., Vashakidze, S., Solomonia, N., Dzidzikashvili, N., Blumberg, H. (2012). Grand Round Calling the Surgeon: The Role of Surgery in the Treatment of Drug-Resistant Tuberculosis. The Lancet, 12(2): 157-166. Doi:10.1016/S1473-3099(11)70244-4.
Nathanson, E., Nunn, P., Uplekar, M., Floyd, K., Jaramillo, E., Lonnroth, K., ... Raviglione, M. (2010). MDR Tuberculosis--Critical Steps for Prevention and Control. The New England Journal of Medicine, (363), 1050-1058. doi:10.1056/NEJMra0908076. National Academy of Sciences. Facing the Reality of Drug-Resistant Tuberculosis in India. Retrieved from http://www.ncbi.nlm.nih.gov/books/NBK100386/
National Institute of Allergy and Infectious Diseases (NIAID). (2007). [Graphic showing XDR-TB]. Extensively Drug-Resistant Tuberculosis (XDR-TB). Retrieved from http://www.niaid.nih.gov/topics/tuberculosis/understanding/whatistb/visualtour/pages/xdr-tb.aspx
Schaaf, H., Moll, A., Dheda, K. (2009). [Graphic showing the process of testing for resistance using DNA strips]. MDR- and XDR-TB in Africa and South America. Retrieved from http://dc269.4shared.com/doc/Owot0-dG/preview.html
ScienceDaily (2006). HIV/AIDS Linked To Extensively Drug Resistant TB. http://www.sciencedaily.com/releases/2006/11/061113170820.htm
Second Line Anti-TB Medications. North Dakota Department of Health, Web. 14 October 2013. <http://www.ndhealth.gov/disease/tb/Documents/Second%20line%20TB%20drugs.pdf >
Shah NS, Wright A, Bai GH, Barrera L, Boulahbal F, Martín-Casabona N, Drobniewski F, Gilpin C, Havelková M, Lepe R, Lumb R, Metchock B, Portaels F, Rodrigues MF, Rüsch-Gerdes S, Van Deun A, Vincent V, Laserson K, Wells C, Cegielski JP. (2007). Worldwide emergence of extensively drug-resistant tuberculosis. Emerg Infect Dis.13(3):380-7.
Shufro, C. (2007). Tracking the Reaper: How a Handful of Doctors Found One of the Deadliest Kinds of TB in the World . Yale Alumni Magazine. http://archives.yalealumnimagazine.com/issues/2007_07/tb.html
Singh, A.K., Maurya, A.K., Kant, S., Umrao, J., Kushwaha, R.A., Nag, V.L., & Dhole, T.N. (2013). Rapid detection of drug resistance and mutational patterns of extensively drug-resistant strains by a novel GenoType® MTBDRsl assay.

return to top | previous page